The goal of this clinical trial is to test a culturally adapted mindfulness-based stress reduction intervention in a community setting for African American adults with high blood pressure (hypertension) and depression. The main questions it aims to answer are: * Does participation in a culturally adapted mindfulness-based intervention improve depressive symptoms? * Does participation in a culturally adapted mindfulness-based intervention improve blood pressure control? * Is the intervention acceptable, appropriate, and feasible as delivered in a community setting? Participants will: * Participate in an 8-week group-based mindfulness intervention (CALM-Chicago). During intervention sessions, participants will learn about mindfulness and stress management and complete mindfulness-based activities, such as guided deep breathing and meditation. * Complete surveys online * Have their blood pressure measured with a non-invasive blood pressure cuff * Attend 1 focus group (optional)
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Effectiveness: Depressive Symptom Response
Timeframe: From enrollment to the end of treatment at 8 weeks
Effectiveness: Systolic Blood Pressure Response
Timeframe: From enrollment to the end of treatment at 8 weeks
Implementation: Acceptability
Timeframe: Assessed every 6 during the clinical trial enrollment and follow-up for up to 3 years
Implementation: Appropriateness
Timeframe: Assessed every 6 during the clinical trial enrollment and follow-up for up to 3 years
Implementation: Feasibility
Timeframe: Assessed every 6 during the clinical trial enrollment and follow-up for up to 3 years